Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

International Influenza

Note: On June 22, 2016, CDC’s Advisory Committee on Immunization Practices (ACIP) recommended a change to U.S. influenza vaccination policy for 2016-2017. The ACIP recommendation must be reviewed and approved by CDC’s Director, and the final recommendations will be published in a CDC Morbidity and Mortality Weekly Report (MMWR), in late summer or early fall. The content of this website will be reviewed and updated prior to the 2016-2017 influenza season.

For the latest summaries of global influenza surveillance, visit Influenza Surveillance and Monitoring. For a summary of influenza activity in the United States, see FluView.

Featured Photo

	International influenza laboratory and surveillance work.

International influenza laboratory and surveillance work.

A study by CDC authors published today in the journal Emerging Infectious Diseases found that CDC’s international capacity-building efforts over a 10-year period (2004-2013) have led to substantial improvements in foreign countries’ ability to conduct influenza surveillance and detect emerging virologic threats. The researchers analyzed surveillance data and program evaluation indicators from 35 countries. The key findings showed substantial increases in laboratory and sentinel surveillance capacities, which are essential for knowing which influenza strains circulate globally, detecting emergence of novel influenza, identifying viruses for vaccine selection, and determining the epidemiology of respiratory illness. Other findings highlighted the progress made in the quality of influenza testing, global contribution to vaccine strain selection, and the extent to which countries believed that the program contributed to their ability to col­lect and report data to WHO FluNet and to prepare for the 2009 influenza A(H1N1) pandemic (pH1N1).

Of the 39 countries that partnered with CDC to improve influenza surveillance capabilities, 36 (92%) transitioned to CDC’s 5-year sustainability cooperative agreement. The number of countries conducting routine virologic sur­veillance for influenza increased from 19 at the start of the capacity-strengthening program to 35 in 2013. All national laboratories supported through the program now use real-time RT-PCR as the primary method to detect circulating influenza.  The proportion of countries reporting data to WHO FluNet for more than 90% of weeks per year increased consider­ably during 2004–2013. Among the 35 responding countries, 26 started the capac­ity-strengthening program before onset of the pH1N1 out­break and many believed that capacity strength­ening played a critical or major role in their pandemic response. Other key ca­pacities described were the ability to understand seasonal trends, establishment of subnational diagnostic laborato­ries, and creation of systems for information sharing be­tween laboratories and sentinel surveillance sites. Overall, 97% of countries reported that they were most­ly or very able to meet their countries’ needs through the program.

The 10-year program was managed through a coopera­tive agreement between CDC and a country’s ministry of health or equivalent national health agency. The first 5 years of the program’s phased approach focused on capac­ity building; over the following 5 years, financial support from CDC was incrementally reduced to encourage the transition of financial support for built routine surveillance systems to the countries. Through the coopera­tive agreement mechanism, the program provided support in 3 ways: providing funding for equipment, materials, and locally employed personnel; conducting hands-on train­ing and long-term technical follow-up with staff within a country; and facilitating participatory, standardized assess­ments of national influenza laboratories, surveillance systems, and core capabilities for influenza pandemic preparedness, each with targeted technical recommendations.

The capacity-strengthening work is focused on two key systems for influenza preparedness: routine laboratory diagnostics to detect seasonal and novel influenza viruses and routine sentinel surveillance for influenza-like illness (ILI) and severe acute respiratory infection (SARI).

For more information on global influenza surveillance, please visit:

The study is available online in Emerging Infectious Diseases


Laos and Nicaragua Expand Flu Protection with Help from CDC and Growing Partnership

	Women chatting in doorway of health clinic.As flu season is wrapping up in the United States, other parts of the world are bracing for the start of their seasons. Thanks to CDC guidance and donations from Partnership for Influenza Vaccine Introduction (PIVI), this year Laos is vaccinating against seasonal influenza for the third year running, and Nicaragua is vaccinating pregnant women against flu for the second year in a row.


Laos and Nicaragua Protect High-Risk Persons from Influenza

	Woman receives seasonal flu vacccination from female nurse in LaosThis season, thanks to a growing coalition of donors and facilitation by CDC, Laos is vaccinating against seasonal influenza for the second year running, and Nicaragua is expanding their existing flu vaccination program to pregnant women.


African Countries Gain Ground in Fight Against Influenza

	Cover image by Dan Higgins, MAMS.The December 15 'Influenza in Africa' supplement gives new data on the burden and epidemiology of seasonal flu in Africa and sheds light on the impact of the 2009 H1N1 pandemic, which tested many countries’ relatively new preparedness plans, laboratory networks and surveillance systems.


International Influenza Activity